Heart damage from COVID-19 may improve over time | Endocarditis after TAVR | A new tool for cardiac care

Researchers focused on long-term heart and lung damage among recovered COVID-19 patients, turning to lung function tests, CT imaging and echocardiograms. 

The authors examined data from more than 134,000 TAVR patients, noting that 65% of endocarditis infections occurred within one year after the procedure. 

The new balloon catheter system provides real-time feedback during minimally invasive surgeries and ablations. 

The CDC emphasized that federal guidelines now recommend against using the two drugs for treating or preventing COVID-19. 

Myocarditis continues to make headlines in the world of college athletics. 

Cardiology’s median compensation is more than $530,000, according to a new report from AMGA Consulting. That figure has increased each year since 2016's report. 

The update is detailed in a September 2020 report published in the Journal of the American College of Cardiology.

The Centers for Medicare and Medicaid Services has agreed on a payment of up to $1,040 per use of the algorithm in patients with suspected LVO. 

A popular and fast-growing consumer healthcare company rooted in technology intends to go public with an initial offering of $100 million in shares.